Disorders of Lipoprotein Metabolism and Other Lipidaemias
Conditions
Keywords
Lipoprotein and Apolipoproteins metabolism
Brief summary
Theranostic translation applications against viral, metabolic liver diseases and hepatic oncogenesis: lipoprotein and apolipoproteins at a crossroad
Detailed description
An intimate link between microbial infections, metabolic changes and oncogenesis has been drawn attentions increasingly, indicating a crossroad leading to pathogenesis and disease progression. Globally the burden of hepatitis B and C virus infections is 450 and 185 millions, respectively and chronic hepatitis disease causes a high risk of liver cirrhosis, hepatocellular carcinoma and metabolic disorders
Interventions
OTHERlipoprotein and apolipoproteins
To find out the role of lipoprotein and apolipoproteins (apos) in pathogenic hepatic diseases
Sponsors
Chun-Hsiang Wang
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
1. above 20 years 2. nonalcoholic fatty liver disease 3. Non-Alcoholic Steatohepatitis
Exclusion criteria
1\. alcohonic hepatitis 2. Autoimmune liver disease 3. HIV postive \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad | 2years | Study the interplay between hepatitis C virus (HCV) and lipid metabolism(the HCV infection affects host lipid homeostasis, regarding transportation, synthesis, and catabolism.) |
Countries
Taiwan
Outcome results
None listed